KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Cash & Equivalents (2021 - 2025)

QuidelOrtho's Cash & Equivalents history spans 4 years, with the latest figure at $98.3 million for Q4 2024.

  • For Q4 2024, Cash & Equivalents fell 17.74% year-over-year to $98.3 million; the TTM value through Dec 2024 reached $98.3 million, down 17.74%, while the annual FY2024 figure was $98.3 million, 17.74% down from the prior year.
  • Cash & Equivalents for Q4 2024 was $98.3 million at QuidelOrtho, down from $144.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.3 billion in Q2 2022 and bottomed at $79.0 million in Q1 2024.
  • The 4-year median for Cash & Equivalents is $213.2 million (2022), against an average of $358.0 million.
  • The largest YoY upside for Cash & Equivalents was 3.94% in 2024 against a maximum downside of 77.74% in 2024.
  • A 4-year view of Cash & Equivalents shows it stood at $578.4 million in 2021, then tumbled by 63.14% to $213.2 million in 2022, then plummeted by 43.95% to $119.5 million in 2023, then dropped by 17.74% to $98.3 million in 2024.
  • Per Business Quant, the three most recent readings for QDEL's Cash & Equivalents are $98.3 million (Q4 2024), $144.0 million (Q3 2024), and $107.5 million (Q2 2024).